Terkko Navigator / Experimental Hematology & Oncology

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified

Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance

Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications

COVID-19 vaccination associated severe immune thrombocytopenia

Progress in molecular feature of smoldering mantle cell lymphoma

Function and clinical significance of N6-methyladenosine in digestive system tumours

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis

Recent advances in Lynch syndrome

Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases

Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine

Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment

The metabolic adaptation mechanism of metastatic organotropism

Histological verification of the treatment effect of tirabrutinib for relapsed/refractory primary central nervous system lymphoma

Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells

Profiling of somatic mutations and fusion genes in acute myeloid leukemia patients with FLT3-ITD or FLT3-TKD mutation at diagnosis reveals distinct evolutionary patterns

Evaluation of acute myeloid leukemia blast percentage on MethylC-Capture Sequencing results

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Natural killer cells associated with SARS-CoV-2 viral RNA shedding, antibody response and mortality in COVID-19 patients

AP-1 family transcription factors: a diverse family of proteins that regulate varied cellular activities in classical hodgkin lymphoma and ALK+ ALCL

Targeting phosphoglycerate dehydrogenase in multiple myeloma

The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers

Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country

CD44 as a tumor biomarker and therapeutic target

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation

Engineering better chimeric antigen receptor T cells

Recent updates for antibody therapy for acute lymphoblastic leukemia

Complex roles of cAMP–PKA–CREB signaling in cancer

Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia

Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma

Trends in disease burden of chronic myeloid leukemia at the global, regional, and national levels: a population-based epidemiologic study

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma

The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017

Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of thera

miR-100 inhibits cell proliferation in mantle cell lymphoma by targeting mTOR

Frontiers in the COVID-19 vaccines development

Regulation of metabolic reprogramming by tumor suppressor genes in pancreatic cancer

Effects of decitabine on allogeneic immune reactions of donor lymphocyte infusion via activation of dendritic cells

Risk factors and outcome of COVID-19 in patients with hematological malignancies